Here you will find a summary of EyePoint Pharmaceuticals' latest financial information. Latest Earnings Release and 10-Q Show all Third Quarter Financial Results Form 10-Q Latest Annual Report and 10-K Show all 2021 Form 10-K 2.7 MB Latest Proxy Statement Form Filing date View DEFA14A Sep 28, 2022 View HTML 0000950170-22-018963.pdf Share Related Items Market Capitalization (Mil) $161.21 Shares Outstanding (Mil) 34.08 Shares Outstanding, Average (FY) (Mil) 28.76 Float (Mil) 30.42 FY = Fiscal Year. MRQ = Most Recent Quarter. mil = Millions. TTM = Trailing Twelve Months. Copyright Refinitiv